Cargando…
Cost-effectiveness of the baclofen versus chlordiazepoxide in alcohol withdrawal syndrome
Autores principales: | Tin, Sim Sai, Wiwanitkit, Viroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375809/ https://www.ncbi.nlm.nih.gov/pubmed/25821327 http://dx.doi.org/10.4103/0253-7613.150379 |
Ejemplares similares
-
Cost-effectiveness analysis of baclofen and chlordiazepoxide in uncomplicated alcohol-withdrawal syndrome
por: Reddy, Vikram K., et al.
Publicado: (2014) -
Baclofen versus lorazepam for alcohol withdrawal
por: Garag, Sagar S., et al.
Publicado: (2019) -
A randomized, open-label, standard controlled, parallel group study of efficacy and safety of baclofen, and chlordiazepoxide in uncomplicated alcohol withdrawal syndrome
por: Girish, K., et al.
Publicado: (2016) -
Fragmented QRS and myocardial performance index in nephrotic syndrome
por: Tin, Sim Sai, et al.
Publicado: (2015) -
To: High-volume hemofiltration and prone ventilation in subarachnoid
hemorrhage complicated by severe acute respiratory distress syndrome and refractory
septic shock
por: Tin, Sim Sai, et al.
Publicado: (2014)